Spyre Therapeutics, Inc. SYRE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-04-07
Spyre Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 2,403,441 | $56.5M |
| MILLENNIUM MANAGEMENT LLC | 146,639 | $7.4M |
| CITADEL ADVISORS LLC | 123,435 | $6.2M |
| AQR CAPITAL MANAGEMENT LLC | 20,874 | $1.1M |
Source: SEC EDGAR filings · CIK 0001636282 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.